Fibroblast growth factor 21, a biomarker for mitochondrial muscle disease
Ralitza Gavrilova1, Rita Horvath
1From the Departments of Medical Genetics and Neurology (R.G.), Mayo Clinic, Rochester, MN; and Newcastle University (R.H.), Newcastle upon Tyne, UK.
Neurology
|October 22, 2013
Abstract
No abstract available in PubMed .


